Nir Sassi
CIK 1760673 · Chief Financial Officer · last filed 2025-12-29
Nir Sassi is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider was granted $54.3K of INDP on Dec 29, 2025. Current disclosed insider exposure totals $95.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$95.8K
2
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INDP | Chief Financial Officer | 26,758 | $3.58 | $95.8K | $0 | 7 | 2025-12-29 |
| Intec Pharma Ltd. (NTEC) Delisted | Chief Financial Officer | — | $9.63 | — | $0 | 4 | 2020-09-18 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-29 | INDP | Grant (A) | +26,758 | $54.3K | EDGAR |
| 2025-04-11 | INDP | Disp (D) | — | $0 | EDGAR |
| 2024-10-10 | INDP | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | INDP | Grant (A) | — | $0 | EDGAR |
| 2023-01-20 | INDP | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | INDP | Grant (A) | — | $0 | EDGAR |
| 2021-08-06 | INDP | Grant (A) | — | $0 | EDGAR |
| 2020-09-18 | Intec Pharma Ltd. (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-19 | Intec Pharma Ltd. (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-16 | Intec Pharma Ltd. (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |